Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628833 · ClinicalTrials.gov registry record · NA
Incontinence Management System ICU Field Evaluation
A NA study of Urinary Incontinence and Fecal Incontinence, sponsored by Hill-Rom.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03628833: Completed NA study of Urinary Incontinence and Fecal Incontinence, sponsored by Hill-Rom.
NCT03628833 is a NA study of Urinary Incontinence and Fecal Incontinence that has completed, run by Hill-Rom. The registered enrollment target is 10 participants, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03628833, a NA study of Urinary Incontinence and Fecal Incontinence, has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this Field Evaluation is to assess usage and satisfaction associated with the Hill-Rom Incontinence Management System.
Primary Outcome
Following product use, staff can complete an optional, Likert scale survey
Conditions Studied
Interventions
- DEVICE Incontinence Management System
Study Locations (1)
Kentucky
- Saint Joseph Hospital - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-10 |
| Est. Completion | 2018-12-03 |
| Phase | NA |
What the finished NCT03628833 record still lists
NCT03628833 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Incontinence Management System is the first listed.
NCT03628833 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03628833 about?
NCT03628833 is a clinical study titled "Incontinence Management System ICU Field Evaluation". The objective of this Field Evaluation is to assess usage and satisfaction associated with the Hill-Rom Incontinence Management System.
What is the current status of trial NCT03628833?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-10. Estimated completion is 2018-12-03.
What conditions does trial NCT03628833 study?
This clinical trial studies the following conditions: Urinary Incontinence, Fecal Incontinence.
What interventions are being tested in trial NCT03628833?
The interventions under investigation include: Incontinence Management System (DEVICE).
Who is sponsoring clinical trial NCT03628833?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03628833 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03628833's enrollment target sits among peer trials
10 46th of 48 the lowest of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI